Date: 4/30/2008
Length: 00:11:50
Size: 5.42MB
Thought Leaders: Dr. Stanley Wulf, Chief Medical Officer, InfoMedics, and Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)
This Podcast covers several key issues related to patient education and patient adherence, including who the key players are, what they can do to improve patient education, and what the pharmaceutical companies can do to raise the effectiveness of patient education.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, May 08, 2008
Late-Phase Research Success: Leveraging Secondary Data
Date: 4/28/2008
Length: 00:16:02
Size: 7.34MB
Thought Leader: Cyndi Verst, Pharm.D., M.S., Senior VP, Global Late Phase, i3 InnovusThis Podcast covers the benefits of blending scientific and commercial objectives in late-phase research — saving time and money — the use of specialized data assets, the challenges of leveraging secondary data assets, and what is in store for late-phase research in the near future.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:16:02
Size: 7.34MB
Thought Leader: Cyndi Verst, Pharm.D., M.S., Senior VP, Global Late Phase, i3 InnovusThis Podcast covers the benefits of blending scientific and commercial objectives in late-phase research — saving time and money — the use of specialized data assets, the challenges of leveraging secondary data assets, and what is in store for late-phase research in the near future.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Enhancing Global Market Access Strategies with Named Patient Programs
Date: 4/23/2008
Length: 00:12:14
Size: 5.60MB
Thought Leaders: John Lagus, VP of Business and Corporate Development, IDIS
This final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.
Play Podcast
Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"
Download RelatedWhite Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:12:14
Size: 5.60MB
Thought Leaders: John Lagus, VP of Business and Corporate Development, IDIS
This final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.
Play Podcast
Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"
Download RelatedWhite Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The Future of Pharma CRM
Date: 4/22/2008
Length: 00:15:43
Size: 7.19MB
Thought Leader: Matt Wallach, VP Sales and Marketing, Verticals onDemand, Inc.
This podcast covers the changing pharmaceutical sales and marketing model and the tools and solutions that are needed to shape the future of salesforces.
Play Podcast
Free Whitepaper Download: "Getting SaaSy In Pharma: How SaaS CRM Technology Today's Beleaguered Pharmaceutical Companies."
Download Related White Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:15:43
Size: 7.19MB
Thought Leader: Matt Wallach, VP Sales and Marketing, Verticals onDemand, Inc.
This podcast covers the changing pharmaceutical sales and marketing model and the tools and solutions that are needed to shape the future of salesforces.
Play Podcast
Free Whitepaper Download: "Getting SaaSy In Pharma: How SaaS CRM Technology Today's Beleaguered Pharmaceutical Companies."
Download Related White Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Silo Busting – New Approaches to Brand Development
Date: 4/2/2008
Length: 00:09:13
Size: 4.21MB
Event Representative: Camille DeSantis, BS, MT (ASCP), Copresident & Managing Partner, Brand Strategy & Client Services, Guard Dog Brand Development LLC
This Podcast covers how brand development agencies and life-sciences companies can partner to achieve optimal results, including breaking down the silos between disciplines. We also cover market research and brand identity ROI, and how to handle soft measurables. And, finally, Ms. DeSantis provides three best practices that can be employed to improve brand value through communications.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Length: 00:09:13
Size: 4.21MB
Event Representative: Camille DeSantis, BS, MT (ASCP), Copresident & Managing Partner, Brand Strategy & Client Services, Guard Dog Brand Development LLC
This Podcast covers how brand development agencies and life-sciences companies can partner to achieve optimal results, including breaking down the silos between disciplines. We also cover market research and brand identity ROI, and how to handle soft measurables. And, finally, Ms. DeSantis provides three best practices that can be employed to improve brand value through communications.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)